Search for publications

Search results

4893 items matching your search terms.

Tailored NEOadjuvant epirubicin, cyclophosphamide and Nanoparticle Albumin-Bound paclitaxel for breast cancer: the phase II NEONAB trial-clinical outcomes and molecular determinants of response

Murphy, C. Muscat, A. Ashley, D. Mukaro, V. West, L. Liao, Y. Chisanga, D. Shi, W. Collins, I. Baron-Hay, S. Patil, S. Lindeman, G. Khasraw, M.
PLOS ONE, 2019     DOI:10.1371/journal.pone.0210891

Effect of the PCSK9 inhibitor evolocumab on total cardiovascular events in patients with cardiovascular disease: A prespecified analysis from the FOURIER trial

Murphy, S. A. Pedersen, T. R. Gaciong, Z. A. Ceska, R. Ezhov, M. V. Connolly, D. L. Jukema, J. W. Toth, K. Tikkanen, M. J. Im, K. Wiviott, S. D. Kurtz, C. E. Honarpour, N. Giugliano, R. P. Keech, A. C. Sever, P. S. Sabatine, M. S.
JAMA CARDIOL, 2019     DOI:10.1001/jamacardio.2019.0886

Sodium-glucose cotransporter inhibitors in type 2 diabetes: thinking beyond glucose lowering

Neuen, B. L. Cherney, D. Z. Jardine, M. J. Perkovic, V.
CMAJ, 2019     DOI:10.1503/cmaj.190047

Effect of Canagliflozin on Renal and Cardiovascular Outcomes across Different Levels of Albuminuria: Data from the CANVAS Program

Neuen, B. L. Ohkuma, T. Neal, B. Matthews, D. R. de Zeeuw, D. Mahaffey, K. W. Fulcher, G. Li, Q. Jardine, M. Oh, R. Heerspink, H. L. Perkovic, V.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019     DOI:10.1681/ASN.2019010064

SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis

Neuen, B. L. Young, T. Heerspink, H. J. L. Neal, B. Perkovic, V. Billot, L. Mahaffey, K. W. Charytan, D. M. Wheeler, D. C. Arnott, C. Bompoint, S. Levin, A. Jardine, M. J.
LANCET DIABETES ENDOCRINOL, 2019     DOI:10.1016/S2213-8587(19)30256-6

False-positive results and incidental findings with annual CT or PET/CT surveillance in asymptomatic patients with resected stage III melanoma

Nijhuis, A. A. G. Dieng, M. Khanna, N. Lord, S. J. Dalton, J. Menzies, A. M. Turner, R. M. Allen, J. Saw, R. P. M. Nieweg, O. E. Thompson, J. F. Morton, R. L.
ANNALS OF SURGICAL ONCOLOGY, 2019     DOI:10.1245/s10434-019-07311-0

U.K. utility weights for the EORTC QLU-C10D

Norman, R. Mercieca-Bebber, R. Rowen, D. Brazier, J. E. Cella, D. Pickard, A. S. Street, D. J. Viney, R. Revicki, D. King, M. T. European Organisation for, Research Treatment of Cancer Quality of Life, Group the, MAUCa Consortium
HEALTH ECONOMICS, 2019     DOI:10.1002/hec.3950

Lipoprotein(a), PCSK9 inhibition, and cardiovascular risk

O'Donoghue, M. L. Fazio, S. Giugliano, R. P. Stroes, E. S. G. Kanevsky, E. Gouni-Berthold, I. Im, K. Lira Pineda, A. Wasserman, S. M. Ceska, R. Ezhov, M. V. Jukema, J. W. Jensen, H. K. Tokgozoglu, S. L. Mach, F. Huber, K. Sever, P. S. Keech, A. C. Pedersen, T. R. Sabatine, M. S.
CIRCULATION, 2019     DOI:10.1161/CIRCULATIONAHA.118.037184

Whole genome and biomarker analysis of patients with recurrent glioblastoma on bevacizumab: a subset analysis of the CABARET trial

Olafson, L. R. Siddell, A. H. Field, K. M. Byrnes, M. Rapkins, R. W. Ng, B. Nixdorf, S. Barnes, E. H. Johns, T. G. Yip, S. Simes, J. Nowak, A. K. Rosenthal, M. A. McDonald, K. L.
JOURNAL OF CLINICAL NEUROSCIENCE, 2019     DOI:10.1016/j.jocn.2019.08.044

High plasma FGF21 levels predicts major cardiovascular events in patients treated with atorvastatin (from the Treating to New Targets [TNT] Study)

Ong, K. L. Hui, N. Januszewski, A. S. Kaakoush, N. O. Xu, A. Fayyad, R. DeMicco, D. A. Jenkins, A. J. Keech, A. C. Waters, D. D. Barter, P. J. Rye, K. A.
METABOLISM: CLINICAL AND EXPERIMENTAL, 2019     DOI:10.1016/j.metabol.2018.11.006

Glucose control using a standard versus an enhanced hybrid closed loop system: a randomized crossover study

Paldus, B. Lee, M. H. Jones, H. M. McAuley, S. A. Horsburgh, J. C. Roem, K. L. Ward, G. M. MacIsaac, R. J. Cohen, N. Colman, P. G. Jenkins, A. J. O'Neal, D. N.
DIABETES TECHNOLOGY AND THERAPEUTICS, 2019     DOI:10.1089/dia.2018.0279

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

Perkovic, V. Jardine, M. J. Neal, B. Bompoint, S. Heerspink, H. J. L. Charytan, D. M. Edwards, R. Agarwal, R. Bakris, G. Bull, S. Cannon, C. P. Capuano, G. Chu, P. L. de Zeeuw, D. Greene, T. Levin, A. Pollock, C. Wheeler, D. C. Yavin, Y. Zhang, H. Zinman, B. Meininger, G. Brenner, B. M. Mahaffey, K. W. Credence Trial Investigators
NEW ENGLAND JOURNAL OF MEDICINE, 2019     DOI:10.1056/NEJMoa1811744

Classification of protein disulphide bonds

Pijning, A. E. Hogg, P.
METHODS IN MOLECULAR BIOLOGY, 2019     DOI:10.1007/978-1-4939-9187-7_1

A novel gene delivery approach using metal organic frameworks in human islet-derived progenitor cells

Poddar, A. Joglekar, M. V. Hardikar, A. A. Shukla, R.
METHODS IN MOLECULAR BIOLOGY, 2019     DOI:10.1007/978-1-4939-9631-5_7

Associations of measures of systemic blood flow used in a randomized trial of delayed cord clamping in preterm infants

Popat, H. Robledo, K. P. Kirby, A. Sebastian, L. Evans, N. Gill, A. Kluckow, M. Sinhal, S. de Waal, K. Tarnow-Mordi, W. Osborn, D.
PEDIATRIC RESEARCH, 2019     DOI:10.1038/s41390-019-0348-1